DK1233788T3 - Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan - Google Patents

Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan

Info

Publication number
DK1233788T3
DK1233788T3 DK00981627T DK00981627T DK1233788T3 DK 1233788 T3 DK1233788 T3 DK 1233788T3 DK 00981627 T DK00981627 T DK 00981627T DK 00981627 T DK00981627 T DK 00981627T DK 1233788 T3 DK1233788 T3 DK 1233788T3
Authority
DK
Denmark
Prior art keywords
carnitine
chitosan
prevention
treatment
disorders due
Prior art date
Application number
DK00981627T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of DK1233788T3 publication Critical patent/DK1233788T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK00981627T 1999-11-18 2000-11-14 Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan DK1233788T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000707A IT1307278B1 (it) 1999-11-18 1999-11-18 Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
PCT/IT2000/000462 WO2001035944A2 (en) 1999-11-18 2000-11-14 Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan

Publications (1)

Publication Number Publication Date
DK1233788T3 true DK1233788T3 (da) 2003-09-01

Family

ID=11407056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00981627T DK1233788T3 (da) 1999-11-18 2000-11-14 Præparat til forebyggelse og/eller behandling af forstyrrelser på grund af abnorm fedtforbrænding indbefattende propionyl-L-carnitin og chitosan

Country Status (19)

Country Link
US (2) US6780851B1 (da)
EP (1) EP1233788B1 (da)
AT (1) ATE239504T1 (da)
AU (1) AU782178C (da)
CA (1) CA2391625C (da)
CZ (1) CZ20021564A3 (da)
DE (1) DE60002607T2 (da)
DK (1) DK1233788T3 (da)
ES (1) ES2197890T3 (da)
HU (1) HU229365B1 (da)
IL (1) IL149619A0 (da)
IT (1) IT1307278B1 (da)
MX (1) MXPA02004987A (da)
NO (1) NO20022288D0 (da)
PL (1) PL204745B1 (da)
PT (1) PT1233788E (da)
SK (1) SK6982002A3 (da)
TN (1) TNSN00216A1 (da)
WO (1) WO2001035944A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
ITRM20010044A1 (it) * 2001-01-29 2002-07-29 Sigma Tau Healthscience Spa Integratore alimentare ad effetto dimagrante.
FR2900054B1 (fr) * 2006-04-21 2012-09-28 Kitozyme Sa Utilisation de polysaccharides d'origine fongique comme composition pharmaceutique ou complements alimentaires pour la sante humaine et animale
US7052722B2 (en) * 2003-12-01 2006-05-30 Cj Corp. Composition for weight reduction comprising water-soluble low-molecular weight chitosan and Hibiscus extract
MXPA05014089A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias inhibidoras de la recaptura de noradrenalina, dopamina y serotonina, combinadas con un aminoacido para el tratamiento de la obesidad y sobrepeso.
ITRM20060204A1 (it) 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
WO2013108263A1 (en) 2012-01-18 2013-07-25 Zota Health Care Ltd Pharmaceutical formulation to reduce inflammation of bones and joint friction with improved cartilage quality
CN105326053A (zh) * 2015-10-03 2016-02-17 王保红 含有左旋肉碱与壳寡糖的组合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
JP3108675B2 (ja) * 1998-03-17 2000-11-13 阪急共栄物産株式会社 脂質代謝改善剤
DK0951909T4 (da) * 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
DK1100344T3 (da) * 1998-07-30 2004-10-11 Vital Living Inc Chitosanholdige flydende præparater og fremgangsmåder til deres fremstilling og anvendelse

Also Published As

Publication number Publication date
PT1233788E (pt) 2003-09-30
IL149619A0 (en) 2002-11-10
NO20022288L (no) 2002-05-14
ITRM990707A0 (it) 1999-11-18
TNSN00216A1 (fr) 2005-11-10
SK6982002A3 (en) 2002-09-10
EP1233788B1 (en) 2003-05-07
ES2197890T3 (es) 2004-01-16
DE60002607D1 (de) 2003-06-12
AU782178C (en) 2006-08-10
CA2391625C (en) 2009-06-30
HUP0203379A3 (en) 2003-12-29
HU229365B1 (hu) 2013-11-28
US8198260B2 (en) 2012-06-12
CA2391625A1 (en) 2001-05-25
WO2001035944A2 (en) 2001-05-25
AU1885101A (en) 2001-05-30
US6780851B1 (en) 2004-08-24
AU782178B2 (en) 2005-07-07
HUP0203379A2 (hu) 2003-02-28
ITRM990707A1 (it) 2001-05-18
US20050020538A1 (en) 2005-01-27
IT1307278B1 (it) 2001-10-30
NO20022288D0 (no) 2002-05-14
PL356183A1 (en) 2004-06-14
ATE239504T1 (de) 2003-05-15
PL204745B1 (pl) 2010-02-26
CZ20021564A3 (cs) 2002-11-13
MXPA02004987A (es) 2003-01-28
WO2001035944A3 (en) 2002-02-07
DE60002607T2 (de) 2004-03-18
EP1233788A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
WO1999066913A3 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
EP1863433A1 (en) Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
EP2263667A3 (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
EP2065040A3 (en) Sphingolipids against pathological processes in lipid rafts
CA2218766A1 (fr) Composes bicycliques-aromatiques
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
NO20022288D0 (no) Sammensetning til forebygging og/eller behandling av forstyrrelser forårsaket av abnorm lipid metabolisme, sominnbefatter propionyl L-karnitin og kitosan
Nadro et al. Evaluation of Moringa oleifera leaf extract on alcohol-induced hepatotoxicity
IS5416A (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
TW200612903A (en) Use of trisubstituted benzopyranones
US20060210653A1 (en) Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
WO2000000183A3 (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
US20080279967A1 (en) Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid
TR200200015T2 (tr) L-Karnitin ve türevleri ile crataegus ekstreleri içeren kardiyoaktif bileşim
JP2002201135A (ja) ラクツロースを含有する上腹部用組成物
IT1291143B1 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina
TNSN06428A1 (en) Product of vegetal origin comprising proanthocyanidines and its preparation process
BRPI0408409A (pt) composição de vacina contra o cólera
JP2005229855A (ja) 食品組成物
CA2588491A1 (en) Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid profile
BRPI0503259A (pt) fitoterápico para tratamento de colesterol e de triglicerìdeo